Pharmaceutical patents and the type of claims
A patent is a legal document that bestows the inventor with an exclusive intellectual property right to prevent others from commercially exploiting the patented invention.
A patent is a legal document that bestows the inventor with an exclusive intellectual property right to prevent others from commercially exploiting the patented invention.
Patent is a type of intellectual property right that provides protection over novel inventions and, gives the innovator an exclusive right to sell, use, create
Eliquis to face generic competition in late 2026? Bristol Myers Squibb (BMS) and Pfizer’s oral blood thinner – Eliquis® (Apixaban) was approved in the United
U.S. FDA approval of BioLineRx’s APHEXDA™ (Motixafortide) in combination with Filgrastim (G-CSF) – a ray of hope for patients with Multiple Myeloma BioLineRx Ltd., a
Tysabri® Biosim approved under REMS program In June 2023, the US district court’s rejection in Biogen vs Sandoz’s Tysabri®’s patent infringement case where Biogen alleged
Stelara® Biosimilars: Relief for plaque psoriasis patients Johnson & Johnson’s (J&J) plaque psoriasis blockbuster drug, Stelara® (Ustekinumab), gained its first approval from U.S. FDA in September 2009.
Welcome to World School of Life Sciences IP, a pioneer in empowering minds to dominate the ever-evolving landscape of patents and pharmaceutical innovations.
Copyright 2023 All right reserved by WSLI. Designed by Webpeckers.